NCT04487717View on ClinicalTrials.gov

Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

581

Participants

Timeline

Start Date

July 29, 2020

Primary Completion Date

October 31, 2029

Study Completion Date

December 31, 2029

Conditions

Gastric Cancer

Interventions

DEVICE

nProfiler I Stomach Cancer Assay Kit

nProfiler I Stomach Cancer Assay Kit (Novomics Co., Korea)

Trial Locations (1)

07217

Novomics, Seoul

All Listed Sponsors

lead

Novomics. Co., Ltd.

INDUSTRY